NCT02881034View on ClinicalTrials.gov

Ribavirin Bioavailability After Telaprevir Exposure

CompletedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Hepatitis C
Interventions
DRUG

Triple therapy

Trial Locations (1)

Unknown

Hôpital de la Croix Rousse, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT02881034 - Ribavirin Bioavailability After Telaprevir Exposure | Biotech Hunter | Biotech Hunter